Copyright: ©Author(s) 2026.
World J Diabetes. Aug 15, 2026; 17(8): 123389
Published online Aug 15, 2026. doi: 10.4239/wjd.123389
Published online Aug 15, 2026. doi: 10.4239/wjd.123389
Table 1 General information comparison, mean ± SD
| OP group (n = 134) | Non-OP group (n = 81) | t/χ2 | P value | |
| Sex | 3.369 | 0.066 | ||
| Male | 28 | 26 | ||
| Female | 106 | 55 | ||
| Age (years) | 72.25 ± 9.08 | 68.84 ± 8.92 | 2.689 | 0.008 |
| Body mass index (kg/m2) | 22.75 ± 3.10 | 22.73 ± 3.12 | 0.063 | 0.950 |
| Disease course (years) | 12.07 ± 6.84 | 70.99 ± 7.44 | 1.084 | 0.280 |
| Smoking history | 21 | 14 | 0.096 | 0.756 |
| Drinking history | 12 | 12 | 1.748 | 0.186 |
| Hypertension | 85 | 48 | 0.373 | 0.542 |
| Peripheral neuropathy | 93 | 47 | 2.877 | 0.090 |
- Citation: Lu HL, Yu F, Zhou HF, Hu P, Gan SL. Clinical significance of bone metabolic markers in osteoporosis-complicated type 2 diabetes mellitus and risk determinants: A retrospective study. World J Diabetes 2026; 17(8): 123389
- URL: https://www.wjgnet.com/1948-9358/full/v17/i8/123389.htm
- DOI: https://dx.doi.org/10.4239/wjd.123389